What does proprietary products — total assets mean?

This represents the total book value of assets specifically allocated to the proprietary products business segment. It includes manufacturing facilities, specialized machinery, and inventory dedicated to supporting the company's core product lines.

West Pharmaceutical Services WST Proprietary Products — Total Assets

Other segment segments

West Vantage

$739.6M—

Similar metrics at other companies

HUNPerformance Products — Total Assets

$1.18B—

BCPCSpecialty Products — Total Assets

$169.77M+1.8%

SCLSpecialty Products — Total Assets

$83.23M+10.0%

GTLSSpecialty Products — Total Assets

$971.5M-1.4%

LEGSpecialized Products — Total Assets

$289.5M-25.1%

TRSSpecialty Products — Total Assets

$86.95M+16.1%

Other financials

Income statement

See full

Revenue$844.9M+21.0%

Gross profit$296.4M+27.8%

Operating income$177.1M+65.5%

Net income$138.8M+54.6%

EPS (diluted)$1.92+56.1%

Balance sheet

See full

Cash & equivalents$521.4M+29.0%

Total debt$321.0M+4.4%

Total equity$3.0B+11.5%

Total assets$4.1B+13.6%

Cash flow

See full

Operating cash flow$89.9M-30.5%

CapEx$42.7M-40.1%

Free cash flow$47.2M-18.8%

Valuation

See full

Market cap$25.36B+64.2%

Enterprise value$25.16B+65.1%

P/E46.7×+15.1×

P/S7.9×+2.7×

Profitability

See full

Gross margin36.3%+1.7pp

Operating margin20.3%+1.2pp

Net margin16.8%+0.7pp

FCF margin14.2%+3.6pp

Returns & leverage

See full

Return on equity19.1%+1.7pp

Debt / equity0.1×0.0×

Current ratio2.7×-0.1×

Where this comes from

Reported directly by West Pharmaceutical Services in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: West Pharmaceutical Services’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about West Pharmaceutical Services's proprietary products — total assets.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is West Pharmaceutical Services's proprietary products — total assets?: West Pharmaceutical Services (WST) reported proprietary products — total assets of $2.93B in Q1 2026.
How has West Pharmaceutical Services's proprietary products — total assets changed year-over-year?: West Pharmaceutical Services's proprietary products — total assets increased by 11.7% year-over-year, from $2.63B to $2.93B.
What does proprietary products — total assets mean?: This represents the total book value of assets specifically allocated to the proprietary products business segment. It includes manufacturing facilities, specialized machinery, and inventory dedicated to supporting the company's core product lines.